SCHEMBL30260613

SCHEMBL30260613

CCC(N)(CC)c1cc(N=Nc2c(O)ccc3c(N=Nc4ccc(O)c(C(N)(CC)CC)c4)c(O)ccc23)ccc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ST14 Q9Y5Y6 1/20 0.39
GLO1 Q04760 3/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
THRB P10828 4/20 0.36
MAPT P10636 5/20 0.36
KMT2A Q03164 4/20 0.36
TDP1 Q9NUW8 3/20 0.36
MEN1 O00255 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
ALPL P05186 1/20 0.36
HSP90AA1 P07900 1/20 0.36
ALPI P09923 1/20 0.36
ALPG P10696 1/20 0.36
CASP3 P42574 1/20 0.36
RECQL P46063 1/20 0.36
MMP14 P50281 1/20 0.36
SENP8 Q96LD8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11269727 0.73 ESR1 (0.46) CYP2C9MAPTKMT2ATDP1MEN1
SCHEMBL111108 0.70 PRKCI (0.46) CYP2C9THRBKMT2ATDP1MEN1
SCHEMBL13856916 0.70 PRKCI (0.51) ST14GLO1CYP1A2CYP2C9THRB
SCHEMBL5619681 0.68 ESR1 (0.36) CYP1A2CYP2C9MAPTKMT2ATDP1
Hydrochloric Acid SCHEMBL6256851 0.68 ACHE (0.47) CYP2C9THRBKMT2ATDP1MEN1
SCHEMBL7035205 0.68 ALDH1A1 (0.38) CYP1A2CYP2C9MAPTKMT2ATDP1
SCHEMBL11140168 0.64 MAPT (0.40) ST14CYP1A2CYP2C9THRBMAPT
SCHEMBL11140167 0.64 MAPT (0.40) ST14CYP1A2CYP2C9THRBMAPT
SCHEMBL1822446 0.63 TSHR (0.52) MAPTTDP1L3MBTL1LMNARECQL
SCHEMBL16153079 0.62 ALDH1A1 (0.62) GLO1CYP1A2CYP2C9MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230044407-A1 TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH TRRAP IN CANCER THE TRUSTEES OF DARTMOUTH COLLEGE 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230044407-A1 TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH TRRAP IN CANCER MYCBP, MYC, TERF2IP ST14 1234/4885GLO1 4391/4885CYP1A2 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.